Melanocytic naevi of lip

CD2_BENIGN_MELANOCYTIC_LIP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.0& Hospital discharge: ICD-9 — 2160A Cause of death: ICD-10 — D22.0& Cause of death: ICD-9 — 2160A 2 out of 7 registries used, show all original rules.	348
4. Check minimum number of events None	348
5. Include endpoints None	348
6. Filter based on genotype QC (FinnGen only)	313

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus (cutis) labii (oris)

NAME	CD2_BENIGN_MELANOCYTIC_LIP
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D220
HD_ICD_9	2160A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D220
COD_ICD_9	2160A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of lip based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2143	1358	781
Only index persons	2030	1302	728
Unadjusted period prevalence (%)
Whole population	0.03	0.04	0.02
Only index persons	0.04	0.05	0.03
Median age at first event (years)
Whole population	39.45	40.56	37.57
Only index persons	38.35	40.23	35.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	313	235	78
Unadjusted period prevalence (%)	0.07	0.08	0.04
Median age at first event (years)	44.31	42.72	49.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
322: Matched controls
3220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D22.0

ICD-10 Finland

Melanocytic naevi of lip

4503599627370496.0

307.7

294

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

7.9

52.3

137

2160A

ICD-9 Finland

Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]

+∞

29.6

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

6.1

28.6

105

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

5.5

22.6

100

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

5.5

22.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.5

19.9

138

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

7.5

16.3

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.9

13.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

9.2

12.3

EAA10

NOMESCO Finland

Excision of lesion of lip

17.4

10.0

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

7.7

9.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.3

8.3

109

9733

FHL

Excision of skin change in operating room or anesthesia

7.7

7.8

XQ848

NOMESCO Finland

Dermatological photography

4.5

7.0

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

3.7

6.8

S82

ICPC

Naevus/mole

2.2

6.6

301

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

6.5

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

161

1164

1.77

5.88

2.6

2.1

—

(3009508) Creatinine [Moles/volume] in Urine

121

890

1.58

3.67

3.3

3.2

6.93

7.45

mmol/l

0.55

752

(3020682) Albumin/Creatinine [Ratio] in Urine

110

833

1.49

2.78

4.1

4.0

8.06

8.18

mg/mmol

0.01

499

(3012516) Albumin [Mass/volume] in Urine

107

810

1.48

2.69

3.5

3.3

32.48

44.87

mg/l

0.51

509

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

142

1168

1.39

2.18

2.2

2.1

97.84

96.22

pmol/l

0.15

601

(44813793) Dust mix specific IgE antibody measurement

3.74

2.16

1.0

—

(1761868) Lipid panel - Serum or Plasma

1221

0.71

2.16

3.3

3.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

2.86

2.01

1.0

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

302

1.57

1.96

2.3

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

205

1.68

1.95

1.2

—

(42870588) Differential panel, method unspecified - Blood

116

937

1.37

1.94

6.0

5.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

3.80

1.94

3.0

2.8

26.75

15.61

mu/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

129

1.84

1.91

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

323

1.53

1.85

1.7

2.7

6.77

7.23

umol/l

0.12

278

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

101

1.94

1.85

1.5

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.21

1.83

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.21

1.83

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

176

1528

1.33

1.80

7.1

6.2

0.22

0.18

e9/l

1.44

160

1336

(3019550) Sodium [Moles/volume] in Serum or Plasma

293

2771

1.64

1.77

18.7

16.5

139.48

139.73

mmol/l

0.89

287

2714

(36660697) Celiac disease serology panel - Serum

253

1.57

1.73

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

121

1000

1.34

1.71

3.4

3.1

28.86

28.96

u/l

0.02

113

957

(3026389) Candida sp identified in Specimen by Organism specific culture

2.48

1.66

1.1

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

292

2772

1.57

19.4

16.7

3.95

mmol/l

0.03

287

2711

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

422

1.43

1.57

3.3

3.0

2.10

3.03

e6/l

0.48

194

(40768793) Breast Pathology biopsy report

1.87

1.54

1.2

1.3

—

(3002256) Pathology report gross observation

372

1.44

1.52

1.5

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

124

1.74

1.51

3.4

2.2

—

(3001604) Monocytes [#/volume] in Blood

168

1473

1.29

1.50

7.2

5.9

0.53

0.55

e9/l

0.69

148

1268

(3006315) Basophils [#/volume] in Blood

168

1477

1.29

1.45

7.2

6.0

0.04

e9/l

0.24

149

1269

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.16

1.44

2.6

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.16

1.44

1.0

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

424

1.39

1.37

1.6

1.7

1343.89

1233.40

nmol/l

0.23

312

(4146454) Self-monitoring of blood glucose

2.97

1.36

1.8

2.9

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

234

2158

1.31

1.34

4.7

4.3

11.65

11.07

mm/h

0.24

223

2025

(3013650) Neutrophils [#/volume] in Blood by Automated count

185

1657

1.27

1.34

10.6

9.5

4.07

4.04

e9/l

0.09

161

1448

(3044242) Glucose [Moles/volume] in Arterial blood

2.80

1.29

2.0

5.4

6.64

8.68

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

456

1.36

1.28

3.3

2.9

0.73

0.86

e6/l

0.21

229

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

108

910

1.28

1.27

2.1

2.4

52.91

66.87

u/l

1.23

102

851

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.66

1.22

1.4

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

126

1.63

1.17

1.5

196.91

241.18

miu/ml

0.28

(3019198) Lymphocytes [#/volume] in Blood

168

1503

1.25

1.17

7.3

6.0

2.00

1.99

e9/l

0.02

156

1330

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

722

1.28

1.15

2.5

2.1

2.64

2.88

mg/l

0.49

625

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.88

1.15

1.6

2.9

1.25

2.87

ratio

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

169

1515

1.24

1.15

5.7

6.0

11.91

10.64

umol/l

0.61

163

1449

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

339

1.38

1.15

2.1

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

231

2150

1.26

1.10

8.4

7.8

76.28

77.59

u/l

0.17

218

2047

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1.97

1.09

2.4

1.9

13.75

13.22

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

298

1.39

1.09

3.6

4.0

2.15

46.14

ug/l

0.97

242

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

158

1412

1.23

1.09

6.8

6.5

1.22

1.21

mmol/l

0.44

140

1206

(3011397) Hemoglobin [Presence] in Urine by Test strip

662

1.28

1.08

3.5

3.8

—

0.29

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

146

1298

1.23

1.04

2.6

80.25

77.43

nmol/l

0.76

134

1192

(3026008) Bacteria identified in Urine by Culture

103

887

1.24

0.99

3.5

2.8

—

(3038026) Centromere Ab [Units/volume] in Serum

2.19

0.98

1.4

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

141

1.52

0.97

2.5

1.8

1.73

5.04

iu/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

183

1.46

0.97

1.2

1.3

27.57

26.46

iu/l

0.05

154

(40768443) Skin Pathology biopsy report

125

1.55

0.96

1.4

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.95

0.0

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

589

1.26

0.94

1.3

1.30

12.57

u/ml

3.84

234

(3052851) Hemolysis interference index of Serum or Plasma

1.69

0.93

4.0

3.1

0.83

2.05

index

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

326

1.33

0.91

5.0

4.4

21.47

22.61

0.20

145

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.61

0.89

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

136

1.50

0.89

1.8

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

300

2912

1.44

0.88

13.3

11.5

25.39

25.22

u/l

0.07

293

2848

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

270

2583

1.28

0.87

6.6

6.0

38.70

38.73

mmol/mol

0.02

252

2451

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.02

0.87

1.5

1.1

—

94.40

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.95

0.85

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

177

0.61

0.84

2.0

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

856

0.81

0.84

4.3

4.0

0.00

0.01

estimate

0.50

328

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

626

1.24

0.83

1.3

1.4

35.70

28.56

iu/ml

0.16

192

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.89

0.82

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

0.00

0.79

0.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.68

0.79

1.3

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.79

0.0

1.6

—

34.00

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

288

2786

1.32

0.78

16.7

14.4

20.23

21.53

mg/l

0.32

228

2271

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.54

0.77

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

124

1.48

0.77

1.7

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

228

1.35

0.76

2.9

2.7

69.07

68.44

ml/min/173m2

0.03

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

241

2289

1.21

0.76

5.4

4.6

14.67

14.65

pmol/l

0.07

225

2127

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

438

1.25

0.74

2.2

—

(3022096) Basophils/Leukocytes in Blood

149

1361

1.18

0.73

7.5

6.0

0.69

0.01

139

1268

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

177

1.38

0.73

1.2

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.02

0.73

2.2

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

275

2651

1.26

0.72

5.3

4.8

5.70

5.84

mmol/l

1.53

257

2461

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

118

1.47

0.71

1.6

1.4

0.86

1.11

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

118

1.47

0.71

1.6

1.4

0.83

1.22

ratio

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

118

1.47

0.71

1.6

1.4

0.80

0.95

ratio

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.68

0.69

1.1

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

102

1.49

0.69

1.3

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

160

1476

1.17

0.68

3.8

3.0

98.80

93.59

ug/l

0.17

153

1391

(3020564) Creatinine [Moles/volume] in Serum or Plasma

298

2905

1.35

0.68

21.0

18.4

76.47

72.87

umol/l

0.74

293

2871

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

215

1.33

0.68

1.6

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

242

1.31

0.67

1.4

2.5

0.23

0.22

g/l

0.50

227

(40768797) Stomach Pathology biopsy report

388

1.25

0.67

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.80

0.66

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

1.80

0.66

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

370

1.25

0.66

2.4

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

454

1.23

0.65

1.6

1.4

236.92

512.14

titre

2.41

112

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

399

1.24

0.64

2.3

2.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.74

0.64

1.2

1.0

—

titre

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.74

0.64

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

222

0.71

0.64

2.4

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

521

1.21

0.64

3.7

3.3

306.56

193.53

ng/l

0.29

365

(4035726) Immunohistochemistry procedure

236

1.30

0.62

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.61

0.62

1.5

1.4

—

(3019069) Monocytes/Leukocytes in Blood

148

1365

1.16

0.62

7.5

6.0

8.28

8.59

0.76

139

1284

(3006504) Eosinophils/Leukocytes in Blood

148

1365

1.16

0.62

7.5

5.9

3.25

2.78

1.24

138

1282

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.68

0.61

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.68

0.61

1.2

1.1

—

(3018010) Neutrophils/Leukocytes in Blood

148

1366

1.15

0.61

7.3

5.9

57.80

56.93

0.43

140

1303

(3003694) ABO and Rh group [Type] in Blood

883

0.85

0.61

1.6

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

542

1.20

0.61

1.8

476.91

26681573.39

pmol/l

0.78

461

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.00

0.60

0.0

1.1

—

468460.71

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

114

1.42

0.60

1.3

1.5

—

15.90

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.59

0.0

1.1

—

38.81

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

591.60

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

313.13

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.48

0.59

1.2

—

(1002224) Polysomnography panel

161

0.67

0.58

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

1.16

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.58

0.0

1.7

—

(3016879) Cocaine [Presence] in Urine

132

1.39

0.58

1.3

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.73

0.58

1.0

1.3

—

nmol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.50

0.58

1.6

1.1

—

(3027008) Opiates [Presence] in Urine

141

1.37

0.58

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

141

1.37

0.58

1.3

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.49

0.57

2.3

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.49

0.57

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.68

0.57

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

661

1.18

0.56

3.9

3.8

1.02

kg/l

0.03

432

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

146

1353

1.14

0.56

3.2

2.6

—

estimate

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.55

0.53

6.8

4.3

27.50

50.24

u/ml

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

108

984

1.15

0.53

3.3

3.2

2.37

2.36

mmol/l

0.35

907

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.44

0.52

2.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

100

1.42

0.52

1.6

1.4

—

(40758558) Short blood count panel - Blood

858

1.15

0.52

8.0

6.6

—

(3019060) Gas panel - Arterial blood

144

1.34

0.52

3.8

7.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1025

0.87

0.51

3.2

3.6

24.30

64.34

ng/l

0.58

675

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

118

1.37

0.51

1.7

1.4

—

(40761511) CBC panel - Blood by Automated count

295

2887

1.26

0.51

16.9

12.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

127

1.36

0.50

1.8

1.5

54.45

57.31

ug/l

0.10

110

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

273

2653

1.19

0.50

6.7

5.6

1.86

1.83

mu/l

0.21

260

2479

(3022621) pH of Urine by Test strip

244

0.76

0.49

1.7

2.3

5.70

6.16

—

158

(3030467) Casts [#/volume] in Urine by Automated count

785

1.15

0.49

3.8

3.1

0.66

0.40

e6/l

0.66

572

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.53

0.48

1.1

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

796

1.15

0.47

1.6

1.7

21.30

21.22

nmol/l

0.02

672

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

137

1276

1.13

0.47

6.0

1.22

mmol/l

0.02

127

1179

(3026493) Urate [Moles/volume] in Serum or Plasma

671

1.15

0.47

2.8

2.6

321.09

326.82

umol/l

0.19

600

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

117

0.68

0.46

1.5

2.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.44

0.46

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

284

1.22

0.46

2.3

31.68

29.22

u/l

0.40

240

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

248

1.23

0.45

3.1

3.0

0.73

0.78

ug/l

0.15

150

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

127

1182

1.12

0.44

1.9

1.39

1.34

mmol/l

0.18

108

1017

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

550

1.16

0.44

2.6

2.8

2.42

2.45

mmol/l

0.98

499

(1001926) Buprenorphine [Presence] in Urine by Screen method

113

1.34

0.43

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

140

1.30

0.43

1.3

1.5

—

(3012544) pH of Venous blood

259

1.22

0.42

3.5

2.7

7.40

7.38

0.74

146

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.57

0.42

1.2

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

102.00

106.03

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

3.96

3.98

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

1.23

1.19

mmol/l

—

(4281824) Cell count and differential, peritoneal fluid

1.52

0.41

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

0.00

0.41

0.0

1.3

—

0.00

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.41

0.0

1.2

—

8.82

—

(3023520) Reticulocytes [#/volume] in Blood

196

1.24

0.40

2.8

65.89

69.43

e9/l

0.28

144

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.40

0.0

2.2

—

(3002030) Lymphocytes/Leukocytes in Blood

148

1396

1.11

0.40

7.6

6.0

27.76

28.56

0.44

141

1328

(3017732) Neutrophils [#/volume] in Blood

374

1.17

0.39

3.3

2.9

4.41

4.95

e9/l

0.27

332

(3027944) Amphetamines [Presence] in Urine

142

1.28

0.39

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

200

1918

1.11

0.39

3.5

3.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.7

—

45.96

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.39

0.39

1.1

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

216

1.22

0.38

3.3

2.4

5.52

4.42

kpa

1.25

211

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

779

1.12

0.38

2.9

3.2

2784.93

1130.31

ng/l

0.40

659

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

114

0.69

0.38

1.9

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

114

0.69

0.38

1.0

1.1

1.61

1.57

g/l

—

114

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

654

1.13

0.37

1.7

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.47

0.36

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.47

0.36

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

617

1.13

0.36

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.44

0.35

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.44

0.35

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.44

0.35

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.44

0.35

1.2

—

(3021788) Differential panel - Synovial fluid

1.44

0.35

2.7

1.6

—

(3015736) pH of Urine

131

1235

1.10

0.35

3.7

3.5

6.46

6.23

1.33

704

(3005033) Fetal Nuchal fold Thickness US

100

1.31

0.34

1.7

1.4

1.15

1.31

—

(3021601) Nitrite [Presence] in Urine by Test strip

161

1536

1.10

0.33

3.9

3.8

0.00

estimate

-0.00

345

(3033658) Prothrombin time (PT) actual/Normal

699

1.11

0.32

3.9

3.6

92.54

92.90

0.04

688

(3025159) Blasts/Leukocytes in Blood

251

0.83

0.32

13.6

4.5

0.00

0.37

—

(3003396) Base excess in Arterial blood by calculation

296

1.17

0.32

4.8

8.9

1.70

1.03

mmol/l

0.60

252

(3035350) Ketones [Presence] in Urine by Test strip

162

1549

1.09

0.31

3.9

0.00

4.59

estimate

0.50

354

(3021589) Normoblasts [#/volume] in Blood

139

1320

1.09

0.31

13.7

10.9

0.00

e9/l

0.67

110

1087

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.30

0.30

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

666

0.90

0.30

2.3

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

384

1.14

0.29

1.8

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.26

0.29

1.1

1.5

—

(40761536) Microorganisms panel - Urine sediment

248

0.84

0.29

2.9

3.7

—

(3037756) Immunofixation for Serum or Plasma

1.23

0.29

1.3

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

792

1.10

0.29

1.4

1.3

0.63

1.80

u/ml

1.23

218

(3043238) Trisomy 21 risk [Likelihood] in Fetus

103

1.27

0.28

1.8

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

118

0.76

0.28

1.0

1.2

0.86

0.92

g/l

—

118

(3019832) Treponema pallidum Ab [Presence] in Serum

393

0.88

0.27

1.9

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

141

1.22

0.26

3.5

2.1

0.66

0.62

0.15

141

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.20

0.26

1.1

1.8

—

(3018095) Leukocytes [#/volume] in Urine

113

1071

1.08

0.26

4.5

4.0

97.81

66.53

e6/l

0.27

738

(3035933) Granulocytes/Leukocytes in Blood

0.68

0.26

5.2

2.7

57.12

59.31

—

(3007164) IgA [Mass/volume] in Serum or Plasma

698

1.10

0.26

1.5

1.3

2.28

2.26

g/l

0.03

424

(3017181) Myelocytes/Leukocytes in Blood

255

0.85

0.25

12.4

4.2

0.60

0.81

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

312

1.14

0.25

2.0

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

837

1.09

0.25

2.2

2.1

209.56

235.30

u/l

0.09

802

(3037121) Protein [Mass/volume] in Urine

1.27

0.24

1.5

3.5

259.17

238.33

mg/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

285

1.14

0.23

7.3

6.4

—

(3004616) Nuclear Ab [Presence] in Serum

1.32

0.23

1.6

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

363

1.12

0.22

5.3

6.3

101.72

104.39

mmol/l

1.58

363

(3019977) pH of Arterial blood

296

1.13

0.22

4.6

8.9

7.42

7.41

0.08

168

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

262

0.87

0.22

1.9

3.68

3.45

mmol/l

0.32

200

(3023419) Bacteria identified in Sputum by Culture

1.22

0.22

3.6

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

921

1.08

0.21

2.2

—

(44806420) Estimation of glomerular filtration rate

1.19

0.21

3.6

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

167

1617

1.07

0.21

3.9

4.8

6.86

6.50

mmol/l

1.30

151

1504

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.21

0.0

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.21

0.0

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

211

1.15

0.21

1.9

1.4

—

(3023368) Bacteria identified in Blood by Culture

686

1.08

0.21

6.8

4.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.17

0.21

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.17

0.21

1.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.21

0.0

1.5

—

23.68

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

3.9

—

210.77

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.20

1.3

2.3

0.00

g/l

—

(3002582) Erythrocytes [#/volume] in Urine

913

1.07

0.20

3.9

3.3

47.86

109.45

e6/l

0.39

697

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

184.74

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.20

0.0

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

174

1.16

0.20

1.3

2.4

—

(21494755) Public health laboratory ask at order entry panel

291

0.88

0.20

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.20

0.20

1.2

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

201

1962

1.07

0.19

3.2

45.39

40.83

u/l

0.38

192

1871

(3009261) Glucose [Presence] in Urine by Test strip

161

1561

1.06

0.19

4.0

3.9

0.00

0.02

estimate

0.79

328

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

156

1.16

0.19

1.7

2.2

12016.74

2100.89

u/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.13

0.19

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

282

2787

1.10

0.18

6.2

5.5

2.71

2.77

mmol/l

0.60

265

2614

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

658

0.93

0.18

1.8

1.7

1.04

1.11

mg/l

0.10

511

(3002523) Influenza virus A Ag [Presence] in Specimen

1.15

0.17

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.15

0.17

1.0

1.1

—

(3032080) INR in Blood by Coagulation assay

127

1226

1.06

0.17

16.1

11.7

1.26

1.19

inr

0.70

1009

(3049717) Cytology report of Urine Cyto stain

1.23

0.17

2.3

2.6

—

(3026782) Osmolality of Urine

545

1.08

0.17

4.4

2.7

535.85

514.95

mosm/kgh2o

0.28

479

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.11

0.17

1.1

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

0.73

0.17

1.0

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.18

0.16

9.9

3.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

409

1.09

0.16

2.2

1.9

—

(3010421) pH of Blood

0.79

0.16

9.3

3.1

7.41

7.42

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

278

2749

1.08

0.15

5.3

4.8

1.53

1.52

mmol/l

0.15

262

2565

(4034850) Laboratory test

1.14

0.15

10.7

9.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.13

0.15

3.0

2.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.13

0.15

1.3

—

0.88

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

263

2597

1.07

0.15

4.5

4.1

1.33

1.25

mmol/l

0.42

243

2408

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.80

0.14

1.0

1.2

—

63.87

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

0.79

0.14

1.0

1.2

9.70

12.32

u/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.77

0.14

1.3

1.8

—

(3008898) HLA-B27 [Presence]

160

1.13

0.14

1.0

1.1

—

(3036489) Thrombin time

110

0.81

0.13

1.7

1.8

20.11

20.62

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

297

1.09

0.13

2.2

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

179

0.89

0.12

1.3

—

(3025941) Bacteria identified in Stool by Culture

172

1.11

0.11

1.2

—

(3000494) Fungus identified in Specimen by Culture

367

1.07

0.11

1.6

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

239

0.91

0.11

12.4

4.4

0.00

0.15

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

675

1.05

0.10

2.3

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

268

0.93

0.09

4.5

3.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

349

0.94

0.09

2.2

2.0

3.52

3.32

ratio

0.52

287

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.11

0.09

1.0

1.2

—

(3019225) pH of Specimen

224

1.08

0.08

3.6

4.1

7.25

7.35

0.37

158

(3028626) Oxygen [Partial pressure] in Capillary blood

0.80

0.08

1.8

2.4

8.10

8.22

kpa

—

(3044290) Cell count panel - Cerebral spinal fluid

0.80

0.08

1.2

1.3

—

(3000492) Spirometry study

297

0.94

0.08

1.6

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.77

0.08

1.0

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

174

0.92

0.08

4.7

6.6

24.74

24.95

mmol/l

0.09

174

(3023511) Choriogonadotropin [Units/volume] in Urine

0.83

0.07

1.0

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.81

0.07

2.5

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

2.0

1.9

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.83

0.07

1.7

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

267

2652

1.04

0.06

16.6

14.1

82.02

84.14

ml/min/173m2

0.89

247

2446

(3002179) Metamyelocytes/Leukocytes in Blood

244

0.94

0.06

11.4

4.1

0.60

0.73

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.12

0.06

1.1

—

(3022313) Gas panel - Capillary blood

1.12

0.06

1.5

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

253

0.94

0.05

1.9

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

208

1.06

0.05

2.8

3.0

21.68

41.16

u/ml

1.48

200

(3020961) Endomysium IgA Ab [Titer] in Serum

171

0.93

0.05

1.1

—

95.17

—

(3050129) First trimester maternal screen panel - Serum or Plasma

150

0.93

0.04

1.6

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

277

2757

1.03

0.04

5.5

4.9

4.72

4.73

mmol/l

0.05

265

2588

(3020891) Body temperature

121

1.08

0.04

5.2

3.8

36.70

36.91

°c

0.38

121

(3003327) Ova and parasites identified in Stool by Light microscopy

122

1.07

0.02

2.8

1.6

—

(3009343) pH of Capillary blood

148

0.94

0.02

1.7

2.9

7.44

7.42

—

120

(3048689) Calprotectin [Mass/mass] in Stool

409

0.97

0.02

1.9

2.4

161.85

110.75

ug/g

0.26

317

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

571

1.02

0.02

2.0

1.7

—

(3022145) Colonoscopy Study observation

353

1.02

0.01

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

717

0.99

0.01

7.2

4.9

—

(3000991) Gas panel - Venous blood

226

0.97

0.00

6.5

7.4

—

(3000850) Epithelial cells [#/volume] in Urine

636

0.99

0.00

3.0

2.7

5.31

7.57

e6/l

0.71

582

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.02

0.00

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

382

0.99

0.00

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.01

0.00

1.3

—

3.14

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.01

0.00

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1.01

0.00

1.3

—

2.98

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

319

1.00

0.00

5.7

4.6

33.24

32.26

0.19

211

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

118

1181

1.00

0.00

4.1

3.6

0.00

0.02

estimate

0.96

291

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

247

1.01

0.00

1.1

1.2

64.95

175.86

u/ml

3.10

102

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

267

1.01

0.00

2.0

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

115

1.05

0.00

1.0

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

114

0.96

0.00

1.4

1.6

—

(4024509) Urine culture

124

0.97

0.00

1.6

2.0

—

(3018418) pH of Serum or Plasma

895

1.01

0.00

5.2

3.7

7.40

0.03

626

(3041096) Erythrocytes [Presence] in Urine by Automated

895

0.99

0.00

3.4

3.2

0.00

estimate

0.50

282

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.90

0.00

2.3

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

3.1

—

0.60

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.94

0.00

1.6

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.94

0.00

1.6

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.00

0.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

6.67

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

-0.00

0.0

1.6

—

57.00

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.93

-0.00

2.1

2.0

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

53.33

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

1.91

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

2.0

—

1.19

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.92

-0.00

9.0

3.0

8.38

9.34

pmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.94

-0.00

1.6

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.96

-0.00

1.2

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.99

-0.00

2.6

2.5

1.24

1.40

mg/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

31.08

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

5.2

—

12.00

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.97

-0.00

2.5

2.6

25.39

24.44

mmol/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.98

-0.00

8.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.00

-0.00

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

15.10

—

(3048879) Bone marrow aspiration report

0.00

-0.00

0.0

1.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

2.6

—

41.40

—

(4094501) Cardiovascular stress test using bicycle ergometer

1.01

-0.00

1.1

—

(1616796) Gas panel - Central venous blood

0.89

-0.00

3.6

2.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

-0.00

0.0

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

100.29

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.67

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.0

—

1.19

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

1.39

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_LIP and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_LIP	0.855 [0.68, 1.07]	0.173
Birth year	1.0 [0.99, 1.01]	0.977

During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 1211 females with CD2_BENIGN_MELANOCYTIC_LIP died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_LIP	1.024 [0.79, 1.32]	0.855
Birth year	0.988 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 689 males with CD2_BENIGN_MELANOCYTIC_LIP died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_LIP.

N-year risk	Females	Males
1	0.102%	0.184%
5	0.639%	1.242%
10	1.545%	3.197%
15	2.804%	5.88%
20	4.939%	10.045%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_LIP – Melanocytic naevi of lip

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi of lip

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints